Caxton Corp Molecular Templates, Inc. Transaction History

Caxton Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $4.13 $192,950 - $351,050	-85,000 Reduced 3.98%	2,052,991 $7.08 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $117,300 - $186,600	15,000 Added 0.71%	2,137,991 $16.7 Million
Q3 2020 Nov 16, 2020	BUY	$9.99 - $14.41 $149,850 - $216,150	15,000 Added 0.71%	2,122,991 $23.2 Million
Q1 2020 May 15, 2020	BUY	$11.31 - $18.26 $169,650 - $273,900	15,000 Added 0.72%	2,107,991 $28 Million
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $3.02 Million - $6.66 Million	468,750 Added 28.86%	2,092,991 $29.3 Million
Q4 2018 Feb 14, 2019	BUY	$3.35 - $5.68 $83,750 - $142,000	25,000 Added 1.56%	1,624,241 $6.56 Million
Q3 2018 Nov 14, 2018	BUY	$4.07 - $6.25 $2.22 Million - $3.41 Million	545,454 Added 51.76%	1,599,241 $8.62 Million
Q2 2018 Aug 14, 2018	BUY	$5.19 - $9.71 $77,850 - $145,650	15,000 Added 1.44%	1,053,787 $0
Q1 2018 May 15, 2018	BUY	$8.0 - $12.96 $200,000 - $324,000	25,000 Added 2.47%	1,038,787 $8.31 Million
Q3 2017 Nov 14, 2017	BUY	$5.0 - $7.14 $5.07 Million - $7.24 Million	1,013,787	1,013,787 $7.07 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.